---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-032986"
form_type: "8-K"
ticker: "LQDA"
cik: "0001819576"
company_name: "Liquidia Corp"
filed_at: "2023-03-16T23:59:59+00:00"
generated_at: "2026-06-18T00:53:03.534579+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Liquidia reports FY 2022 revenue $15.9M, net loss $41.0M; YUTREPIA launch path by H1 2024

## Summary
- Revenue $15.9M (+23% YoY); net loss $41.0M ($0.67/share) vs $34.6M loss in 2021.
- Legal resolution for YUTREPIA expected late 2023 to H1 2024; PTAB invalidated '793 patent.
- Cash $93.3M at Dec 31, 2022; HCRx revenue interest financing up to $100M ($32.5M funded).
- New CEO, CMO, Head of Sales; collaboration with Mainbridge for repurposed infusion pump.
- Amended Sandoz promotion agreement extends to 2032; pump repair costs split equally.

## SEC filing metadata
- accession: 0001104659-23-032986
- form_type: 8-K
- ticker: LQDA
- cik: 0001819576
- company_name: Liquidia Corp
- filed_at: 2023-03-16T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819576/000110465923032986/0001104659-23-032986-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819576/000110465923032986/tm239718d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-032986
- JSON: https://secwatch.observer/filing/0001104659-23-032986.json
- Plain text: https://secwatch.observer/filing/0001104659-23-032986.txt

## Key facts
- Earnings Releases
  Liquidia Corp reported financial results for full year ended December 31, 2022.
  - Period: full year ended December 31, 2022
  - Result: reported results
  source text: issued a press release announcing its financial results for the full year ended December 31, 2022, and also provided a corporate update.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819576/000110465923032986/0001104659-23-032986-index.htm
- Material Agreements
  Liquidia Corp amended Fourth Amendment to Promotion Agreement with Sandoz Inc. (effective 2023-03-10).
  - Action: amendment
  - Counterparty: Sandoz Inc.
  - Effective: 2023-03-10
  source text: On March 10, 2023, Liquidia PAH, LLC, a Delaware limited liability company (formerly known as RareGen, LLC) (“Liquidia PAH”) and wholly-owned subsidiary of Liquidia Corporation, a Delaware corporation (the “Company”), entered into a Fourth Amendment to Promotion Agreement (the “Fourth Amendment”) with Sandoz Inc. (“Sandoz”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819576/000110465923032986/0001104659-23-032986-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.